CNR2 anticorps (C-Term)
-
- Antigène Voir toutes CNR2 Anticorps
- CNR2 (Cannabinoid Receptor 2 (CNR2))
-
Épitope
- C-Term
-
Reactivité
- Humain, Rat, Souris, Cheval
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CNR2 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- MVNPVIYALR SGEIRSSAHH CLAHWKKCVR GLGSEAKEEA PRSSVTETEA
- Homologie
- Horse: 83%, Human: 100%, Mouse: 79%, Rat: 86%
- Attributs du produit
- This is a rabbit polyclonal antibody against CNR2. It was validated on Western Blot.
- Purification
- Affinity Purified
- Top Product
- Discover our top product CNR2 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 360 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells." dans: The Journal of biological chemistry, Vol. 289, Issue 19, pp. 13079-100, (2014) (PubMed).
: "
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells." dans: The Journal of biological chemistry, Vol. 289, Issue 19, pp. 13079-100, (2014) (PubMed).
-
- Antigène
- CNR2 (Cannabinoid Receptor 2 (CNR2))
- Autre désignation
- CNR2 (CNR2 Produits)
- Synonymes
- anticorps CNR2, anticorps CB2, anticorps cb2a, anticorps cb2b, anticorps CB-2, anticorps CX5, anticorps CB2C, anticorps CNR2C, anticorps CB2-R, anticorps cannabinoid receptor 2, anticorps cannabinoid receptor 2 (macrophage), anticorps CNR2, anticorps cnr2, anticorps Cnr2
- Sujet
-
The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. The proteins encoded by this gene and the cannabinoid receptor 1 (brain) (CNR1) gene have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.
Alias Symbols: CB2, CX5
Protein Interaction Partner: GNA15,
Protein Size: 360 - Poids moléculaire
- 40 kDa
- ID gène
- 1269
- NCBI Accession
- NM_001841, NP_001832
- UniProt
- P34972
-